Xylem Inc. (XYL) Stock Price & Analysis
Xylem Inc. (XYL) closed at USD 109.26 on Thursday, October 22, 2026, up 2.74% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 106.35; the Oct 22, 2026 session ranged USD 103.45–109.51 on volume of 2,632,951 shares. Market capitalization is $25.51B, with a 52-week range of USD 98.58–154.27 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/XYL.md
Key facts (XYL)
- Last four reported quarters (through Jun 30, 2026): revenue $9.13B, net income $1.02B (11.2% margin), free cash flow $960M (SEC filings).
- Valuation: P/E 25.1x (avg 35.8x at the last 3 fiscal year-ends), EV/EBITDA 14.4x, net debt $1.67B.
- 1 of 80 tracked superinvestors hold XYL (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.14 on a 1–5 scale) (21 analysts), mean target USD 142.63 (range 110–180).
- Total return with dividends: 1Y -25.0% vs S&P 500 +14.9%; 5Y -9.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-27, EPS estimate USD 1.45, revenue estimate $2.28B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (XYL)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.20B | $5.52B | $7.36B | $8.56B | $9.04B | $9.13B |
| Gross profit | $1.98B | $2.08B | $2.72B | $3.21B | $3.48B | — |
| Operating income | $585M | $622M | $652M | $1.01B | $1.22B | $1.32B |
| Net income | $427M | $355M | $609M | $890M | $957M | $1.02B |
| EPS (diluted) | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 | — |
| Free cash flow | $330M | $388M | $566M | $942M | $910M | $960M |
| Gross margin | 38.0% | 37.7% | 36.9% | 37.5% | 38.5% | — |
| Operating margin | 11.3% | 11.3% | 8.9% | 11.8% | 13.5% | 14.5% |
| Net margin | 8.2% | 6.4% | 8.3% | 10.4% | 10.6% | 11.2% |
| Revenue growth | +6.5% | +6.3% | +33.4% | +16.3% | +5.5% | — |
| Cash + short-term investments | — | $944M | $1.02B | $1.12B | $1.48B | — |
| Total debt | $2.44B | $1.88B | $2.28B | $2.03B | $1.95B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (XYL)
P/E 25.1x · P/S 2.8x · EV/EBITDA 14.4x · EV/Sales 3.0x · P/FCF 26.6x · P/B 2.5x · FCF yield 3.76% · Earnings yield 3.99% · Dividend yield (paid, TTM) 1.58% · Buyback yield (TTM) 4.88% · Net debt $1.67B · EV $27.2B
P/E at fiscal year-ends: Dec 2025 34.7x, Dec 2024 31.7x, Dec 2023 41.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (XYL)
1 of 80 tracked investors hold XYL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Mairs & Power | Mairs & Power Funds | 0.02% | $1.8M | Added +9.7% |
Analysts (XYL)
Consensus Buy (mean 2.14 on a 1–5 scale), 21 analysts; mean target USD 142.63 (low 110, high 180).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | JP Morgan | Target lowered | Neutral | $137 → $118 |
| 2026-10-15 | Mizuho | Target lowered | Neutral | $130 → $110 |
| 2026-10-14 | Oppenheimer | Target lowered | Outperform | $158 → $150 |
| 2026-10-14 | RBC Capital | Target lowered | Outperform | $164 → $135 |
| 2026-10-13 | Barclays | Target lowered | Overweight | $159 → $139 |
| 2026-10-12 | Citigroup | Target lowered | Buy | $172 → $148 |
| 2026-10-05 | UBS | Target lowered | Neutral | $138 → $112 |
| 2026-08-24 | Jefferies | Target raised | Buy | $145 → $150 |
| 2026-08-13 | UBS | Target raised | Neutral | $135 → $138 |
| 2026-07-30 | UBS | Target raised | Neutral | $129 → $135 |
| 2026-07-29 | Stifel | Target raised | Buy | $157 → $160 |
| 2026-07-29 | Mizuho | Target raised | Neutral | $124 → $130 |
Total return (dividends reinvested) (XYL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -25.0% | -9.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -25.1% | -2.0% |
| Volatility (annualized) | 25.7% | 26.8% |
| Max drawdown | -33.1% (Oct 2025→Oct 2026) | -43.8% (Nov 2021→Jun 2022) |
XYL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.45 | $1.46 | -0.7% | $2.28B | 18 |
| Next quarter (ends Dec 2026) | $1.64 | $1.63 | +0.5% | $2.45B | 17 |
| Current fiscal year (ends Dec 2026) | $5.65 | $5.54 | +2.0% | $9.19B | 20 |
| Next fiscal year (ends Dec 2027) | $6.22 | $6.10 | +1.8% | $9.61B | 20 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 109.26 |
|---|---|
| Change | ▲ 2.74% (up) |
| Previous Close | USD 106.35 |
| Open | USD 104.73 |
| Day Range | USD 103.45 – 109.51 |
| 52-Week Range | USD 98.58 – 154.27 |
| Volume | 2,632,951 shares |
| Market Cap | $25.51B |
| Exchange | NYQ |
Technical Analysis (XYL)
Nexqual's technical model rates XYL "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 68.91 (neutral) |
| vs SMA50 | Above (USD 107.43) |
| MACD | -0.28 (negative) |
Analyst Ratings (XYL)
Wall Street analysts rate XYL "Buy" based on 21 analysts, with a mean price target of USD 142.63 (range USD 110–180), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 142.63 |
| High Target | USD 180 |
| Low Target | USD 110 |
| Buy / Hold / Sell | 14 / 7 / 0 |
Earnings (XYL)
| Next Earnings Date | 2026-10-27 |
|---|---|
| EPS Estimate | USD 1.45 |
| Revenue Estimate | $2.28B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.46 vs est 1.34 ▲ beat |
| 2026-03-31 | USD 1.12 vs est 1.08 ▲ beat |
| 2025-12-31 | USD 1.42 vs est 1.41 ▲ beat |
| 2025-09-30 | USD 1.37 vs est 1.23 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (XYL)
| Total Revenue | $9.13B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +1.50% |
| Gross Margin | +39.24% |
| Operating Margin | +17.00% |
| Profit Margin | +11.15% |
| ROE | +9.18% |
| Debt / Equity | 0.29 |
| Current Ratio | 1.61 |
| Total Cash | $1.28B |
| Total Debt | $3.06B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $960.00M (10.5% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (XYL)
Nexqual rates Xylem Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 39%, operating 17% (last 12 months) |
| Balance Sheet | Strong — $1.28B cash and investments vs $2.95B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $960M (last 4 quarters to Jun 2026, SEC), 11% margin |
| Efficiency | Mixed — ROE 9%, ROA 5.1% |
Ownership (XYL)
| Insider Ownership | +0.34% |
|---|---|
| Institutional Ownership | +97.69% |
| Shares Outstanding | 233.49M |
| Float | 232.88M |
| Short % of Float | +5.75% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (XYL)
Xylem Inc. is led by Matthew Francis Pine, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| CEO, President & Director | Matthew Francis Pine |
|---|---|
| Executive VP & President of Water Infrastructure | Hayati Yarkadas |
| Executive VP and President of Integrated Services & Solutions | Rodney O. Aulick |
| Executive VP & CFO | Andrea van der Berg |
| Executive VP & COO | Thomas F. Pettit |
Major Backers & Investors (XYL)
Notable institutional backers of Xylem Inc. include Invesco, Royal Bank of Canada, Impax Asset Management Group plc, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 2.19% |
| Royal Bank of Canada | 1.97% |
| Impax Asset Management Group plc | 1.91% |
| Fidelity | 1.32% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.05% |
| BlackRock | 10.72% |
| State Street | 4.9% |
| Geode Capital | 2.72% |
| Amundi | 2.19% |
| BNY Mellon | 2% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOV | Dover Corporation | USD 195.49 | ▼ 2.18% |
| OTIS | Otis Worldwide Corporation | USD 75.6 | ▲ 4.49% |
| IR | Ingersoll Rand Inc. | USD 74.11 | ▼ 6.26% |
| NDSN | Nordson Corporation | USD 318.71 | ▼ 3.87% |
| IEX | IDEX Corporation | USD 226.88 | ▼ 3.63% |
| GGG | Graco Inc. | USD 69.28 | ▼ 15.32% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt